Log in
Enquire now
‌

US Patent 10576133 BCMA chimeric antigen receptors

Patent 10576133 was granted and assigned to Bluebird Bio on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Bluebird Bio
Bluebird Bio
0
Current Assignee
Bluebird Bio
Bluebird Bio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105761330
Patent Inventor Names
Richard Morgan0
Kevin Friedman0
Date of Patent
March 3, 2020
0
Patent Application Number
165029660
Date Filed
July 3, 2019
0
Patent Citations
‌
US Patent 10479975 Methods of making T cell compositions
Patent Primary Examiner
‌
Christopher M Babic
0
Patent abstract

The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10576133 BCMA chimeric antigen receptors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.